Generics

Aurobindo's fenofibrate capsules will be available in dosage strengths of 67 mg, 134 mg and 200 mg.

Evoclin Foam had a market value of approximately $12 million for the 12 months endedJuly 2021, according to IQVIA.

Chantix had a market value of approximately $1 billion for the 12 months ended June 30, according to IQVIA.

Biosimilar drugs saved $7.9 billion dollars in 2020 alone, more than tripling the $2.5 billion saved in 2019, according to the latest report from the Association for Accessible Medicines.

Camber's nebivolol tablets provide a generic treatment for patients with hypertension.

Hikma will be responsible for commercializing Bilastine once it is FDA approved.

Durezol had a market value of approximately $106 million for the 12-month period ended June 2021, according to IQVIA.

The goal of the pilot program is to allow American and European assessors the ability to concurrently exchange their views with applicants on scientific issues during the development phase of complex generic/hybrid products.